These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16246051)

  • 21. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
    Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
    Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
    Marcello E; Epis R; Di Luca M
    Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
    Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
    Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons.
    Schneider A; Schulz-Schaeffer W; Hartmann T; Schulz JB; Simons M
    Neurobiol Dis; 2006 Sep; 23(3):573-7. PubMed ID: 16777421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
    Arbel M; Solomon B
    Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly.
    Losic D; Martin LL; Mechler A; Aguilar MI; Small DH
    J Struct Biol; 2006 Jul; 155(1):104-10. PubMed ID: 16650774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain.
    Ishibashi K; Tomiyama T; Nishitsuji K; Hara M; Mori H
    J Neurosci Res; 2006 Aug; 84(3):632-6. PubMed ID: 16721760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention.
    Eckman EA; Eckman CB
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1101-5. PubMed ID: 16246055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
    Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A beta oligomers - a decade of discovery.
    Walsh DM; Selkoe DJ
    J Neurochem; 2007 Jun; 101(5):1172-84. PubMed ID: 17286590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
    DaSilva KA; Brown ME; McLaurin J
    Vaccine; 2009 Feb; 27(9):1365-76. PubMed ID: 19150380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.